Q2 2020 Coherus BioSciences Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Coherus Biosciences 2020 Second Quarter Earnings Conference Call. My name is Nora, and I'll be your conference operator for the call today. As a reminder, this conference call is being recorded.
I would now like to turn the call over to David Arrington, Coherus Investor Relations and Corporate Affairs. Please go ahead.
Thank you, Nora, and good afternoon, everyone. After close of market today, we issued a press release on our second quarter financial results. This release can be found on the Coherus Biosciences website. Joining me for today's call will be Denny Lanfear, Coherus' CEO; Dr. Jean Viret, Chief Financial Officer; Thomas Fitzpatrick, Chief Legal Officer; and Chris Thompson, Executive Vice President, Sales.
Before we begin our formal remarks, I would like to remind you that we will be making forward-looking statements, including risks and uncertainties related to the impact of COVID-19
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |